ORSIRO Trademark

Trademark Overview


On Monday, December 1, 2014, a trademark application was filed for ORSIRO with the United States Patent and Trademark Office. The USPTO has given the ORSIRO trademark a serial number of 79164728. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Thursday, May 5, 2022. This trademark is owned by Biotronik AG. The ORSIRO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

[ Chemical and pharmaceutical preparations for medical use, namely, medicated polymer-based preparations, including limus preparations of polyester, polylactic limus preparations and inorganic preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for medical use for improving the biocompatibility of implants, namely, the coating of stents; chemical and pharmaceutical preparations for medical use for improving the healing of implants, namely, medicated stents; chemical products for pharmaceutical use, namely, medicated polymer-based preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for cardiovascular and vascular procedures; drugs for medical use, namely, medicines belonging to the family of limus, namely, derivatives of limus, sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for the treatment of cardiovascular and vascular dise...

Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants consisting of artificial materials and surgical instruments; catheters; catheters for percutaneous transluminal coronary angioplasty (PTCA catheters) and catheters for percutaneous translumial angioplasty (PTA catheters), namely, balloon dilatation catheters; medical apparatus and instruments, namely, balloon catheters and stents; stents which can expand by means of balloons; [ self-expanding stents; ] drug-eluting stents [ ; absorbable stents; absorbable drug-eluting stents ]
orsiro

General Information


Serial Number79164728
Word MarkORSIRO
Filing DateMonday, December 1, 2014
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateThursday, May 5, 2022
Registration Number4879106
Registration DateTuesday, January 5, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2015

Trademark Statements


Goods and Services[ Chemical and pharmaceutical preparations for medical use, namely, medicated polymer-based preparations, including limus preparations of polyester, polylactic limus preparations and inorganic preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for medical use for improving the biocompatibility of implants, namely, the coating of stents; chemical and pharmaceutical preparations for medical use for improving the healing of implants, namely, medicated stents; chemical products for pharmaceutical use, namely, medicated polymer-based preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for cardiovascular and vascular procedures; drugs for medical use, namely, medicines belonging to the family of limus, namely, derivatives of limus, sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for the treatment of cardiovascular and vascular diseases; medicines for human use for use in cardiovascular and vascular procedures ]
Translation of Words in MarkThe word(s) "ORSIRO" has no meaning in a foreign language.
Goods and ServicesSurgical and medical apparatus and instruments, namely, vascular and cardiovascular implants consisting of artificial materials and surgical instruments; catheters; catheters for percutaneous transluminal coronary angioplasty (PTCA catheters) and catheters for percutaneous translumial angioplasty (PTA catheters), namely, balloon dilatation catheters; medical apparatus and instruments, namely, balloon catheters and stents; stents which can expand by means of balloons; [ self-expanding stents; ] drug-eluting stents [ ; absorbable stents; absorbable drug-eluting stents ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, May 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiotronik AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBülach CH-8180
CH

Party NameBiotronik AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameBiotronik AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, February 24, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 24, 2023INVALIDATION PROCESSED
Thursday, January 5, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, May 5, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, May 5, 2022REGISTERED - PARTIAL SEC 71 ACCEPTED
Thursday, May 5, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 5, 2021TEAS SECTION 71 RECEIVED
Saturday, June 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 5, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, April 19, 2018CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, March 9, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Friday, May 12, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 16, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 6, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 6, 2016FINAL DISPOSITION PROCESSED
Tuesday, April 5, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 5, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, October 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2015PUBLISHED FOR OPPOSITION
Friday, October 2, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 11, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 1, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 1, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 24, 2015ASSIGNED TO LIE
Wednesday, August 5, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 23, 2015NEW REPRESENTATIVE AT IB RECEIVED
Sunday, June 7, 2015REFUSAL PROCESSED BY IB
Thursday, May 21, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 21, 2015REFUSAL PROCESSED BY MPU
Thursday, May 21, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 20, 2015NON-FINAL ACTION WRITTEN
Saturday, May 16, 2015APPLICATION FILING RECEIPT MAILED
Tuesday, May 12, 2015ASSIGNED TO EXAMINER
Tuesday, May 12, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 7, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB